Raj Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 3.10 M
as on 20-12-2024
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.41 Cr
as on 20-12-2024
- Revenue 21.55%
(FY 2022)
- Profit 24.03%
(FY 2022)
- Ebitda 13.73%
(FY 2022)
- Net Worth 28.87%
(FY 2022)
- Total Assets 23.51%
(FY 2022)
About Raj Eye Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 3.10 M.
The company currently has active open charges totaling ₹4.41 Cr.
Mahesh Lal, Anil Srivastava, Rupam Srivastava, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110UP1995PTC018893
- Company No.
018893
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Raj Eye Hospital?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Srivastava  | Director | 13-Oct-1995 | Current |
| Mahesh Lal | Director | 13-Oct-1995 | Current |
| Rupam Srivastava | Director | 13-Oct-1995 | Current |
| Rajeev Kumar | Director | 13-Oct-1995 | Current |
| Raj Srivastava | Additional Director | 31-Dec-2017 | Current |
| Riya Srivastava | Director | 08-May-2024 | Current |
Financial Performance of Raj Eye Hospital.
Raj Eye Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.55% increase. The company also saw a substantial improvement in profitability, with a 24.03% increase in profit. The company's net worth Soared by an impressive increase of 28.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raj Eye Hospital?
In 2021, Raj Eye Hospital had a promoter holding of 70.74% and a public holding of 29.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 27 Feb 2015 | ₹7.00 M | Open |
State Bank Of India Creation Date: 03 Aug 2007 | ₹7.30 M | Open |
Icici Bank Limited Creation Date: 31 Mar 2005 | ₹3.40 M | Open |
How Many Employees Work at Raj Eye Hospital?
Unlock and access historical data on people associated with Raj Eye Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raj Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raj Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
